Literature DB >> 26806866

Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.

Lamei Yuan1, Zhi Song2, Xiong Deng3, Wei Xiong4, Zhijian Yang3, Hao Deng5.   

Abstract

Parkinson's disease (PD) is a common age-dependent neurodegenerative movement disorder related to multiple factors, and genetic factors play an important role in the pathogenesis of PD. Variants in the methylenetetrahydrofolate reductase gene (MTHFR), a gene encoding a folate-dependent enzyme that is involved in homocysteine metabolism, have been reported to be associated with PD. To explore the role of the MTHFR gene in the development of PD in Chinese Han population, we analyzed two MTHFR variants (rs1801131 and rs1801133) in a patient cohort consisting of 512 patients with PD from mainland China and a control cohort consisting of 512 age, gender and ethnicity matched normal subjects. Statistically significant differences in genotypic and allelic frequencies were detected in the MTHFR variant rs1801133 (P=0.022 and 0.007, respectively; odds ratio=0.780, 95% confidence interval=0.651-0.934). In addition, the A-T haplotype of rs1801131-rs1801133 showed a protective role against PD development (P=0.007, odds ratio=0.779, 95% confidence interval=0.650-0.933). Our results suggested that the T allele of rs1801133 variant and A-T haplotype of rs1801131-rs1801133 in the MTHFR gene may decrease the risk of developing PD in Chinese Han population from mainland China.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  MTHFR gene; Parkinson’s disease; Variant; rs1801131; rs1801133

Mesh:

Substances:

Year:  2016        PMID: 26806866     DOI: 10.1016/j.neulet.2016.01.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson's Disease.

Authors:  Lamei Yuan; Zhi Song; Xiong Deng; Zhijian Yang; Yan Yang; Yi Guo; Hongwei Lu; Hao Deng
Journal:  Neurosci Bull       Date:  2017-03-24       Impact factor: 5.203

2.  A duplex polymerase chain reaction-restriction fragment length polymorphism for rapid screening of methylenetetrahydrofolate reductase gene variants: Genotyping in acute leukemia.

Authors:  Rim Frikha; Nouha Bouayed; Bochra Ben Rhouma; Leila Keskes; Tarek Rebai
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

3.  Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy.

Authors:  Yang Zhang; Zongjuan Li; Jian Zhang; Hongsheng Li; Yumei Qiao; Chengsuo Huang; Baosheng Li
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

4.  Association Between MTHFR Genetic Polymorphism and Parkinson's Disease Susceptibility: A Meta-analysis.

Authors:  Hong-Mei Diao; Zheng-Feng Song; Hai-Dong Xu
Journal:  Open Med (Wars)       Date:  2019-08-17

5.  Differences in MTHFR and LRRK2 variant's association with sporadic Parkinson's disease in Mexican Mestizos correlated to Native American ancestry.

Authors:  Elizabeth Romero-Gutiérrez; Paola Vázquez-Cárdenas; Hortensia Moreno-Macías; José Salas-Pacheco; Teresa Tusié-Luna; Oscar Arias-Carrión
Journal:  NPJ Parkinsons Dis       Date:  2021-02-11

6.  The protective effects of the methylenetetrahydrofolate reductase rs1801131 variant among Saudi smokers.

Authors:  Mikhlid H Almutairi; Nouf S Al-Numair; Narasimha Reddy Parine; Bader O Almutairi; Abdulwahed F Alrefaei; Mahmoud Rouabhia; Abdelhabib Semlali
Journal:  Saudi J Biol Sci       Date:  2021-04-13       Impact factor: 4.219

7.  Systematic analysis of genetic variants in Han Chinese patients with sporadic Parkinson's disease.

Authors:  Lamei Yuan; Zhi Song; Xiong Deng; Wen Zheng; Yi Guo; Zhijian Yang; Hao Deng
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

Review 8.  Implications of DNA Methylation in Parkinson's Disease.

Authors:  Ernesto Miranda-Morales; Karin Meier; Ada Sandoval-Carrillo; José Salas-Pacheco; Paola Vázquez-Cárdenas; Oscar Arias-Carrión
Journal:  Front Mol Neurosci       Date:  2017-07-18       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.